Capillaries News and Research

RSS

ARDS may not be the primary lung iInjury in COVID-19

A new Italian study published on the preprint server medRxiv in August 2020 shows that this may not be an adequate explanation, since ARDS is a nonspecific diagnosis. Instead, they say, antemortem lung biopsy shows a “Covid pattern” of acute lung injury, which could guide the application of therapeutics.

16 Aug 2020

Scientists identify new treatment targets for blinding retinal disease

When the eye isn't getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists have identified new points where they may be able to calm the frenzy and instead enable recovery

10 Aug 2020

Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients

Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.

29 Jul 2020

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

A new study of human olfactory cells has revealed that viral invasion of supportive cells in the nasal cavity might be driving the loss of smell seen in some patients with COVID-19.

25 Jul 2020

Autopsies reveal unexpected changes in the hearts of COVID-19 patients

A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.

21 Jul 2020

COVID-19 complications may be associated with von Willebrand factor in the blood

Anna Aksenova, a senior research associate at the Laboratory of Amyloid Biology at St Petersburg University, has advanced a hypothesis that the severe course of COVID-19 may be associated with von Willebrand factor.

6 Jul 2020

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

3 Jul 2020

Blood cell damage in COVID-19 may compromise oxygen transport

Researchers in the U.S. have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may alter key protein structures on red blood cells and compromise the transport and delivery of oxygen in patients with coronavirus disease 2019 (COVID-19).

1 Jul 2020

Artificial red blood cells mimic the favorable properties of natural ones

Scientists have tried to develop synthetic red blood cells that mimic the favorable properties of natural ones, such as flexibility, oxygen transport and long circulation times.

3 Jun 2020

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Various diseases in humans and animals - such as tumors, strokes or chronic kidney disease - damage the blood vessels. Capillaries, the smallest blood vessels in the body, are particularly affected.

26 May 2020

Inexpensive screening method for retinal changes in diabetics

Retinal damage due to diabetes is now considered the most common cause of blindness in working-age adults.

25 May 2020

Capillary leakage important in COVID-19 respiratory distress

Now, a new study published on the preprint server medRxiv reports the pivotal role played by protein leakage through lung capillaries and promotes the use of serum albumin as a biomarker of disease progression and severity.

24 May 2020

Tocilizumab improves survival in COVID-19 patients with ARDS

The current COVID-19 pandemic caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), has already nearly 4.8 million confirmed cases and more than 318,000 deaths.

18 May 2020

Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate

The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial conducted in the world to test whether the defibrotide medicine, which has already been authorized to treat a severe obstruction of the hepatic sinusoidal veins of people who have undergone a bone marrow transplant, can be used as therapy against COVID-19.

12 May 2020

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

A study conducted by a team of researchers at LSU Health New Orleans has shown for the first time that chronic exposure to inhaled nicotine alone increases blood pressure (hypertension), in both the body's general circulation and in the lungs that can lead to pulmonary hypertension.

4 May 2020

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Researchers at the Radboud University Medical Center seem to have found an essential mechanism in the disease process of COVID-19, which has so far been overlooked.

29 Apr 2020

Study reveals how APOE4 triggers leaks in the blood-brain barrier

New USC research reveals how APOE4, a genetic culprit for Alzheimer's disease, triggers leaks in the brain's plumbing system, allowing toxic substances to seep into the brain areas responsible for memory encoding and other cognitive functions.

29 Apr 2020

Study: E-cigarettes damage vascular function much like traditional cigarettes

Using e-cigarettes damages the arteries and blood vessel function much like smoking traditional cigarettes, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association, and funded through the Tobacco Center of Regulatory Science of the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives.

29 Apr 2020

The Latest Electron Paramagnetic Resonance (EPR) Spectroscopy Technology

In this interview, Kalina Ranguelova, Senior EPR Application Scientist at Bruker BioSpin, discusses the newest member of benchtop EPS spectrometers family, the Magnettech ESR 5000.

From Bruker BioSpin Group 22 Apr 2020

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in patients with COVID-19.

8 Apr 2020

Capillaries News and Research

ARDS may not be the primary lung iInjury in COVID-19

Scientists identify new treatment targets for blinding retinal disease

Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

Autopsies reveal unexpected changes in the hearts of COVID-19 patients

COVID-19 complications may be associated with von Willebrand factor in the blood

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

Blood cell damage in COVID-19 may compromise oxygen transport

Artificial red blood cells mimic the favorable properties of natural ones

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Inexpensive screening method for retinal changes in diabetics

Capillary leakage important in COVID-19 respiratory distress

Tocilizumab improves survival in COVID-19 patients with ARDS

Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Study reveals how APOE4 triggers leaks in the blood-brain barrier

Study: E-cigarettes damage vascular function much like traditional cigarettes

The Latest Electron Paramagnetic Resonance (EPR) Spectroscopy Technology

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News